Henderson Jane - Insider Non-Derivative Transactions at Akero Therapeutics, Inc. (AKRO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 16, 2023, Henderson Jane's relationship to Akero Therapeutics, Inc. (AKRO) is Director, and currently has 40,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other AKRO insiders.
Data Source: SEC.
Henderson Jane - Insider Non-Derivative Transactions at AKRO
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Jun 17, 2023 | Sell -- (Common Stock) | 22498 | 54.46 | 0 |
Jun 17, 2023 | Sell -- (Common Stock) | 17502 | 53.79 | 22498 |
Jun 17, 2023 | M -- (Common Stock) | 40000 | 7.01 | 40000 |